These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30453100)

  • 1. Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.
    Ando N; Furuichi Y; Kasai S; Tamai M; Harama D; Kagami K; Abe M; Goi K; Inukai T; Sugita K
    Leuk Res; 2018 Dec; 75():36-44. PubMed ID: 30453100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.
    Tamai M; Furuichi Y; Kasai S; Ando N; Harama D; Goi K; Inukai T; Kagami K; Abe M; Ichikawa H; Sugita K
    Leuk Res; 2017 Oct; 61():68-76. PubMed ID: 28917156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.
    Heckmann D; Maier P; Laufs S; Li L; Sleeman JP; Trunk MJ; Leupold JH; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
    Clin Cancer Res; 2014 Feb; 20(3):604-16. PubMed ID: 24255072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.
    Grymula K; Tarnowski M; Wysoczynski M; Drukala J; Barr FG; Ratajczak J; Kucia M; Ratajczak MZ
    Int J Cancer; 2010 Dec; 127(11):2554-68. PubMed ID: 20162608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition.
    Sison EA; Magoon D; Li L; Annesley CE; Rau RE; Small D; Brown P
    Oncotarget; 2014 Oct; 5(19):8947-58. PubMed ID: 25333254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLL-Rearranged Acute Lymphoblastic Leukemia.
    El Chaer F; Keng M; Ballen KK
    Curr Hematol Malig Rep; 2020 Apr; 15(2):83-89. PubMed ID: 32350732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.
    Sison EA; Rau RE; McIntyre E; Li L; Small D; Brown P
    Br J Haematol; 2013 Mar; 160(6):785-97. PubMed ID: 23294096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents.
    Furuichi Y; Goi K; Inukai T; Sato H; Nemoto A; Takahashi K; Akahane K; Hirose K; Honna H; Kuroda I; Zhang X; Kagami K; Hayashi Y; Harigaya K; Nakazawa S; Sugita K
    Cancer Res; 2007 Oct; 67(20):9852-61. PubMed ID: 17942916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of an interaction between TGF-β1 and the SDF-1/CXCR4/CXCR7 axis in human platelets.
    Rath D; Chatterjee M; Holtkamp A; Tekath N; Borst O; Vogel S; Müller K; Gawaz M; Geisler T
    Thromb Res; 2016 Aug; 144():79-84. PubMed ID: 27314628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery.
    Rath D; Chatterjee M; Borst O; Müller K; Stellos K; Mack AF; Bongartz A; Bigalke B; Langer H; Schwab M; Gawaz M; Geisler T
    Eur Heart J; 2014 Feb; 35(6):386-94. PubMed ID: 24168792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation.
    Ngamsri KC; Jans C; Putri RA; Schindler K; Gamper-Tsigaras J; Eggstein C; Köhler D; Konrad FM
    Front Immunol; 2020; 11():407. PubMed ID: 32210974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal cell-derived factor-1 exerts opposing roles through CXCR4 and CXCR7 in angiotensin II-induced adventitial remodeling.
    Song B; Chen D; Liu Z; Cheng Y; Zhang Z; Han W; Zhang R; Gong Y
    Biochem Biophys Res Commun; 2022 Feb; 594():38-45. PubMed ID: 35066378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration.
    Hunger C; Ödemis V; Engele J
    Exp Cell Res; 2012 Oct; 318(17):2178-90. PubMed ID: 22766125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations.
    Kerstjens M; Driessen EM; Willekes M; Pinhanços SS; Schneider P; Pieters R; Stam RW
    Oncotarget; 2017 Feb; 8(9):14835-14846. PubMed ID: 27588400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDF-1α induces differential trafficking of CXCR4-CXCR7 involving cyclophilin A, CXCR7 ubiquitination and promotes platelet survival.
    Chatterjee M; Seizer P; Borst O; Schönberger T; Mack A; Geisler T; Langer HF; May AE; Vogel S; Lang F; Gawaz M
    FASEB J; 2014 Jul; 28(7):2864-78. PubMed ID: 24668750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain.
    Schönemeier B; Kolodziej A; Schulz S; Jacobs S; Hoellt V; Stumm R
    J Comp Neurol; 2008 Sep; 510(2):207-20. PubMed ID: 18615560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases.
    Liepelt A; Tacke F
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G203-9. PubMed ID: 27313175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells.
    Dai X; Tan Y; Cai S; Xiong X; Wang L; Ye Q; Yan X; Ma K; Cai L
    J Cell Mol Med; 2011 Jun; 15(6):1299-309. PubMed ID: 21418513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia.
    Imayoshi N; Yoshioka M; Tanaka K; Yang SM; Akahane K; Toda Y; Hosogi S; Inukai T; Okada S; Maloney DJ; Nakahata T; Takita J; Kato I; Ashihara E
    Biochem Biophys Res Commun; 2022 Jan; 590():49-54. PubMed ID: 34971957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia.
    Lipfert J; Ödemis V; Wagner DC; Boltze J; Engele J
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):667-80. PubMed ID: 23289420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.